Literature DB >> 11120054

Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.

M Niimi1, Y Ikeda, N Shirasugi, T Shatari, H Takami, S Kodaira, K Matsumoto, K Hamano, K Esato, M Hara, K J Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11120054     DOI： 10.1016/s0041-1345(00)01546-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  1 in total

1.  Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

Authors:  Vanessa Oliveira; Birgit Sawitzki; Stephanie Chapman; Christine Appelt; Inga Gebuhr; Joanna Wieckiewicz; Elaine Long; Kathryn J Wood
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.